These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 38560569)
1. Dual ligand-targeted Pluronic P123 polymeric micelles enhance the therapeutic effect of breast cancer with bone metastases. Gao H; Zhang J; Kleijn TG; Wu Z; Liu B; Ma Y; Ding B; Yin D Oncol Res; 2024; 32(4):769-784. PubMed ID: 38560569 [TBL] [Abstract][Full Text] [Related]
2. Dual targeting curcumin loaded alendronate-hyaluronan- octadecanoic acid micelles for improving osteosarcoma therapy. Xi Y; Jiang T; Yu Y; Yu J; Xue M; Xu N; Wen J; Wang W; He H; Shen Y; Chen D; Ye X; Webster TJ Int J Nanomedicine; 2019; 14():6425-6437. PubMed ID: 31496695 [TBL] [Abstract][Full Text] [Related]
3. Pluronic P123 modified nano micelles loaded with doxorubicin enhanced tumor-suppressing effect on drug-resistant breast cancer cells. Zhang X; Chen W; Bai J; Jin L; Kang X; Zhang H; Wang Z Aging (Albany NY); 2020 May; 12(9):8289-8300. PubMed ID: 32396524 [TBL] [Abstract][Full Text] [Related]
4. Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery. Damke GMZF; Souza RP; Montanha MC; Damke E; Gonçalves RS; César GB; Kimura E; Caetano W; Hioka N; Consolaro MEL Anticancer Agents Med Chem; 2020; 20(11):1352-1367. PubMed ID: 30387402 [TBL] [Abstract][Full Text] [Related]
5. Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy. Zhu J; Huo Q; Xu M; Yang F; Li Y; Shi H; Niu Y; Liu Y Nanoscale; 2018 Oct; 10(38):18387-18397. PubMed ID: 30256367 [TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer. Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507 [TBL] [Abstract][Full Text] [Related]
7. Bioreducible PAA-g-PEG graft micelles with high doxorubicin loading for targeted antitumor effect against mouse breast carcinoma. Sun Y; Zou W; Bian S; Huang Y; Tan Y; Liang J; Fan Y; Zhang X Biomaterials; 2013 Sep; 34(28):6818-28. PubMed ID: 23764117 [TBL] [Abstract][Full Text] [Related]
8. Polymeric complex micelles with double drug-loading strategies for folate-mediated paclitaxel delivery. Li M; Liu Y; Feng L; Liu F; Zhang L; Zhang N Colloids Surf B Biointerfaces; 2015 Jul; 131():191-201. PubMed ID: 25988283 [TBL] [Abstract][Full Text] [Related]
9. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin. Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241 [TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases. Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349 [TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Wei Z; Hao J; Yuan S; Li Y; Juan W; Sha X; Fang X Int J Pharm; 2009 Jul; 376(1-2):176-85. PubMed ID: 19409463 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity. Wei Z; Yuan S; Hao J; Fang X Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310 [TBL] [Abstract][Full Text] [Related]
13. Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis. Liu T; Romanova S; Wang S; Hyun MA; Zhang C; Cohen SM; Singh RK; Bronich TK Mol Pharm; 2019 Jul; 16(7):2872-2883. PubMed ID: 31150251 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of doxorubicin-loaded pH-sensitive polymeric micelle release from tumor blood vessels and anticancer efficacy using a dorsal skin-fold window chamber model. Jin ZH; Jin MJ; Jiang CG; Yin XZ; Jin SX; Quan XQ; Gao ZG Acta Pharmacol Sin; 2014 Jun; 35(6):839-45. PubMed ID: 24902790 [TBL] [Abstract][Full Text] [Related]
15. pH-sensitive pluronic micelles combined with oxidative stress amplification for enhancing multidrug resistance breast cancer therapy. Cheng X; Zeng X; Zheng Y; Fang Q; Wang X; Wang J; Tang R J Colloid Interface Sci; 2020 Apr; 565():254-269. PubMed ID: 31978788 [TBL] [Abstract][Full Text] [Related]
16. Docetaxel-loaded pluronic p123 polymeric micelles: in vitro and in vivo evaluation. Liu Z; Liu D; Wang L; Zhang J; Zhang N Int J Mol Sci; 2011; 12(3):1684-96. PubMed ID: 21673916 [TBL] [Abstract][Full Text] [Related]
17. Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption. Zhao YP; Ye WL; Liu DZ; Cui H; Cheng Y; Liu M; Zhang BL; Mei QB; Zhou SY Nanoscale; 2017 May; 9(19):6264-6277. PubMed ID: 28470315 [TBL] [Abstract][Full Text] [Related]
18. In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer. Wang K; Guo C; Dong X; Yu Y; Wang B; Liu W; Chen D Mol Pharm; 2018 Jul; 15(7):2764-2769. PubMed ID: 29792799 [TBL] [Abstract][Full Text] [Related]
19. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration. Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182 [TBL] [Abstract][Full Text] [Related]
20. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor. Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]